Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

315
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
315
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

113
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
113

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of key substances and mechanisms of action for the pleasurable aroma of Shaoxing Huangjiu based on GC-MS, molecular docking, and sensory evaluation.

Food chemistry·2026
Same author

Impact of chronic comorbidities on psychological and social status in COVID-19 patients.

Frontiers in psychology·2026
Same author

Benzo[a]pyrene carcinogenicity across organs and cancer stages: Molecular mechanisms and interactions with co-exposed chemicals.

Environmental pollution (Barking, Essex : 1987)·2026
Same author

Lichang decoction suppresses AOM+DSS-induced colitis-associated cancer via regulating intestinal flora and suppressing the Wnt/β-catenin signaling pathway.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2026
Same author

Hypertension management profiles in Chinese adults aged 60 years and older.

Frontiers in public health·2026
Same author

A study on the antitumor effect and mechanism of arsenic trioxide on lung adenocarcinoma.

Journal of cancer research and therapeutics·2026

Related Experiment Video

Updated: May 22, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.0K

Latent class analysis-derived classification for cancer-specific death stratification of hepatocellular carcinoma.

Xiaoyan Jiang1, Qianyuan Zhang2, Ziying Zheng2

  • 1Department of Gestational and Toxic Hepatopathy, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian, People's Republic of China.

International Journal of Cancer
|March 12, 2025
PubMed
Summary

This study identified four hepatocellular carcinoma (HCC) subtypes using latent class analysis (LCA). These subtypes improve HCC-specific mortality prediction and guide personalized treatment strategies for better patient outcomes.

Keywords:
cancer‐specific deathcompleting risks modelhepatocellular carcinomalatent class analysispersonalized treatment

More Related Videos

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
07:32

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

1.2K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K

Related Experiment Videos

Last Updated: May 22, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.0K
Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
07:32

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

1.2K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K

Area of Science:

  • Oncology
  • Medical Statistics
  • Cancer Research

Background:

  • Hepatocellular carcinoma (HCC) exhibits significant heterogeneity in survival and treatment response, complicating mortality prediction.
  • Accurate assessment of HCC-specific mortality is crucial for effective clinical management and treatment planning.

Purpose of the Study:

  • To identify distinct hepatocellular carcinoma (HCC) subtypes using latent class analysis (LCA).
  • To improve the prediction of HCC-specific mortality and optimize treatment recommendations based on identified subtypes.

Main Methods:

  • Latent class analysis (LCA) applied to demographic and clinicopathological data from 7746 HCC patients (SEER database).
  • Cox proportional hazards regression and competing risks models used to evaluate survival and mortality across subtypes.
  • External validation conducted on a separate cohort of 6791 patients.

Main Results:

  • Four distinct HCC subtypes (LCAC1-LCAC4) were identified.
  • Subtypes LCAC2 and LCAC4 showed significantly shorter overall survival compared to LCAC1.
  • LCAC2 exhibited the highest HCC-specific mortality, while LCAC3 had the lowest non-HCC-specific mortality.
  • Surgical treatment, especially preoperative systemic therapy, improved survival across all subtypes; chemotherapy/radiotherapy had limited efficacy in LCAC1 and LCAC3.

Conclusions:

  • The identified HCC subtypes offer a novel classification system for differentiating HCC-specific mortality.
  • This classification aids in accurate survival stratification and personalized treatment recommendations.
  • Findings provide valuable insights for clinical decision-making in hepatocellular carcinoma management.